Eleven Biotherapeutics (EBIO) Shares Tick Higher Early
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Eleven Biotherapeutics (NASDAQ: EBIO) shares are seeing early buying. The stock is up around 1.8 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GenVec (GNVC) halted again LUDP last up 30%
- Lululemon Athletica (LULU) December weekly volatility increases to 85 into Q3 and outlook
- Options with increasing call volume; CI KKR DYN ETFC MUR CCI WDAY P LOW EBAY